🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I'm really excited to continue the decade+ collaboration w/ the brilliant Joe Pierre as we unravel the contribution of the #Mycobiome to Hirschsprung-Associated Enterocolitis #HAEC pathogenesis.

Hey #medtwitter…Interested in pediatric surgery? surgical oncology? Research? One year fellowship opening St. Jude in pediatric surgical oncology. You’ll work with great colleagues like Andrew J Murphy. I can personally vouch for this great experience. Call Gailya: 901-595-4060

Hey #medtwitter…Interested in pediatric surgery? surgical oncology? Research? One year clinical fellowship opening St. Jude Research in pediatric surgical oncology starting as soon as possible. Details: stjude.org/education-trai… PSORC APSA Surgeons IPSO

Yes we are! My laboratory is looking for a senior or lead research technician to take on challenging projects in immune profiling of osteosarcoma tumors and surgical modeling! Please take a look amd consider joining this highly cohesive and collaborative group!

Inspiring talk today at St. Jude from pediatric surgical oncologist Dr. Lindsay Talbot on building a program to leverage chemokine-mediated homing of CAR T cells in pediatric #osteosarcoma. 🔬St. Jude Research

Get to know our new Program Director, Dr Bethany Slater! Bethany Slater specialty: pediatric surgery hometown: NYC when outside the hospital she might be: running a marathon, traveling the world, playing tennis, or trying out a new restaurant favorite part of the job: helping kids

Excited to share Peter Chockley's work on Synapse-tuned CARs out in Nature Biotech today Nature Biotechnology Stephen Gottschalk St. Jude Research Synapse-tuned CARs enhance immune cell anti-tumor activity | Nature Biotechnology nature.com/articles/s4158…

First corresponding paper is out! Thank you to Jorge and @GiedreKrenciute for the beautiful imaging and brain tumor models, Lindsay Talbot for the stunning HALO assay, and Stephen Gottschalk for the mentorship and support. All made possible by St. Jude and St. Jude Research

“We've come up with a way to more efficiently and effectively bind and target cancer cells,” Peter Chockley says. Discover how his ‘molecular anchor’ improved chimeric antigen receptors against multiple cancer types in Nature Biotechnology. stjude.org/CAR-anchor-dom… #immunotherapy

So blessed to be part of the Duke Surgery family! #pedsurgbestsurg

Great showing from Duke Pediatric Surgery today at #APSA2023 on topics ranging from global surgery to biliary surgery to cancer control plans! Duke General Surgery Residency Harold Leraas, M.D. Lisa Tracy

⁦Lindsay Talbot⁩ speaking in Young Investigator Symposium ⁦APSA Surgeons⁩ on leveraging CAR T cell strategies to improve osteosarcoma outcomes! Phenomenal work from an outstanding pediatric surgeon scientist! 🙌👏👊 ⁦St. Jude⁩

Our ACS National Surgeon Scientist Program (NSSP) and NCI Early-stage Surgeon Scientist Program (ESSP) awardees met on NIH's campus today for their first in-person symposium! A huge thank you to our experts for joining. National Cancer Institute @NCI_Training NIH American College of Surgeons

Check out our recent study in BioRxiv! A high-throughput screen to identify small molecules that enhance antigen expression to enhance B7-H3 #CART cells targeting #osteosarcoma. A collaboration between the DeRenzoLab & Dr. Taosheng Chen St. Jude Research biorxiv.org/content/10.110…

Don’t forget to check out Lindsay Talbot poster on her #PSORC study investigating the use of palliative site-directed ablative therapy in pediatric oncology American Academy of Pediatrics #AAP2023. Great work!

Scientists identified chemokines expressed by osteosarcoma that enhanced CAR T-cell homing, presenting a promising new strategy to improve antitumor activity. This work is a significant step forward in the development of immunotherapy for solid tumors. ow.ly/Y7pn50SRv35

Come to think of it, denigrating the worth of a soldier’s service based on whether he deployed to a war zone is… kind of like denigrating the worth of a woman’s citizenship based on whether she happens to have children.

Thrilled to announce our latest publication in Science Magazine describing a reverse-translation study that defines the core regulators of T cell stemness that can be exploited to improve immunotherapy! Tae Gun Kang, PhD St. Jude Research Stand Up To Cancer Van Andel Institute (VAI) science.org/doi/10.1126/sc…